Found 13 matching trials
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia PHASE3 Drugs used in chemotherapy use different ways to stop cancer cells from div...
Show More Location
Cancer and Leukemia Group B
Learn More & Join Trial
A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833 PHASE1 This is a dosage escalation study to estimate the maximum tolerated dose of...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia PHASE3 Randomized phase III trial to compare the effectiveness of combination chem...
Show More Location
Cancer and Leukemia Group B
Learn More & Join Trial
Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
University of California San Diego Cancer Center
Learn More & Join Trial
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 PHASE1 The clinical study entitled "A Phase I Study of Infusional Chemotherapy wit...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
University of California San Diego Cancer Center
Learn More & Join Trial
Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer PHASE2 RATIONALE: Some tumors become resistant to chemotherapy drugs. Combining PS...
Show More Location
Veterans Affairs Medical Center - Palo Alto
Learn More & Join Trial
Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia PHASE1 Phase I trial to study the effectiveness of PSC-833 plus etoposide and mito...
Show More Location
University of Arkansas for Medical Sciences
Learn More & Join Trial
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
MBCCOP - University of South Alabama
Learn More & Join Trial
Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Queen Elizabeth Hospital at University of Birmingham
Learn More & Join Trial